Effect of FXR agonist GW4064 in the treatment of hilar cholangiocarcinoma in rats
Crossref DOI link: https://doi.org/10.1038/s41598-022-23539-5
Published Online: 2022-11-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Jie-ping
Zhang, Meng-yu
Luo, Ming
Qin, Shu
Xia, Xian-ming
Text and Data Mining valid from 2022-11-07
Version of Record valid from 2022-11-07
Article History
Received: 18 July 2022
Accepted: 1 November 2022
First Online: 7 November 2022
Competing interests
: The authors declare no competing interests.